Successful treatment of Cronkhite–Canada syndrome using anti-tumor necrosis factor antibody therapy
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
Successful treatment of Cronkhite–Canada syndrome using anti-tumor necrosis factor antibody therapy ; volume:46 ; number:S 01 ; year:2014 ; pages:E476-E477 ; 01
Endoscopy ; 46, Heft S 01 (2014), E476-E477, 01
- Beteiligte Personen und Organisationen
-
Watanabe, Daisuke
Ooi, Makoto
Hoshi, Namiko
Kohashi, Michitaka
Yoshie, Tomoo
Ikehara, Nobunao
Yoshida, Masaru
Yanagita, Emmy
Yamasaki, Takashi
Itoh, Tomoo
Azuma, Takeshi
- DOI
-
10.1055/s-0034-1377539
- URN
-
urn:nbn:de:101:1-2019050612215146736074
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:55 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Watanabe, Daisuke
- Ooi, Makoto
- Hoshi, Namiko
- Kohashi, Michitaka
- Yoshie, Tomoo
- Ikehara, Nobunao
- Yoshida, Masaru
- Yanagita, Emmy
- Yamasaki, Takashi
- Itoh, Tomoo
- Azuma, Takeshi
Ähnliche Objekte (12)
Successful treatment with anti-tumor necrosis factor alpha for reactive small-bowel amyloidosis
Remission of Behcet's disease with anti-tumor necrosis factor monoclonal antibody therapy: a case report
Golimumab: A Novel Anti-Tumor Necrosis Factor
T cell lymphoproliferative disorders associated with anti-tumor necrosis factor alpha antibody therapy for ulcerative colitis: literature summary
Anti-tumor necrosis factor therapy in inflammatory bowel disease : 15 tables
Successful conservative treatment for massive tracheal necrosis after lung segmentectomy
Update on intravitreal anti-tumor necrosis factor alpha therapies for ocular disorders
Ipilimumab augments antitumor activity of bispecific antibody-armed T cells
Anti-tumor action of tumor necrosis factor against Bomirski Ab melanoma in hamsters
Factors that influence rheumatologists’ anti-tumor necrosis factor alpha prescribing decisions: a qualitative study
Anti-tumor necrosis factor patent expiration and the risks of biocopies in clinical practice
Evolution of the antagonistic tumor necrosis factor receptor one-specific antibody ATROSAB
Successful treatment with anti-tumor necrosis factor alpha for reactive small-bowel amyloidosis
Remission of Behcet's disease with anti-tumor necrosis factor monoclonal antibody therapy: a case report
Golimumab: A Novel Anti-Tumor Necrosis Factor
T cell lymphoproliferative disorders associated with anti-tumor necrosis factor alpha antibody therapy for ulcerative colitis: literature summary
Anti-tumor necrosis factor therapy in inflammatory bowel disease : 15 tables
Successful conservative treatment for massive tracheal necrosis after lung segmentectomy
Update on intravitreal anti-tumor necrosis factor alpha therapies for ocular disorders
Ipilimumab augments antitumor activity of bispecific antibody-armed T cells
Anti-tumor action of tumor necrosis factor against Bomirski Ab melanoma in hamsters
Factors that influence rheumatologists’ anti-tumor necrosis factor alpha prescribing decisions: a qualitative study
Anti-tumor necrosis factor patent expiration and the risks of biocopies in clinical practice
Evolution of the antagonistic tumor necrosis factor receptor one-specific antibody ATROSAB
Successful treatment with anti-tumor necrosis factor alpha for reactive small-bowel amyloidosis
Remission of Behcet's disease with anti-tumor necrosis factor monoclonal antibody therapy: a case report
Golimumab: A Novel Anti-Tumor Necrosis Factor
T cell lymphoproliferative disorders associated with anti-tumor necrosis factor alpha antibody therapy for ulcerative colitis: literature summary
Anti-tumor necrosis factor therapy in inflammatory bowel disease : 15 tables
Successful conservative treatment for massive tracheal necrosis after lung segmentectomy
Update on intravitreal anti-tumor necrosis factor alpha therapies for ocular disorders
Ipilimumab augments antitumor activity of bispecific antibody-armed T cells
Anti-tumor action of tumor necrosis factor against Bomirski Ab melanoma in hamsters
Factors that influence rheumatologists’ anti-tumor necrosis factor alpha prescribing decisions: a qualitative study
Anti-tumor necrosis factor patent expiration and the risks of biocopies in clinical practice